Incidence and Management of Ruptured Angiomyolipoma

Risk Stratification and Surveillance

The risk of spontaneous hemorrhage in small AMLs (<4 cm) is very low, and these lesions warrant surveillance with ultrasound every 3 years without treatment intervention 1, 2
Medium to Large AMLs (≥4 cm) have a substantially increased bleeding risk, particularly above 4 cm, and tumors >6 cm require more intensive monitoring every 6 months due to higher bleeding risk 1, 2
TSC-associated AMLs are larger, more frequently bilateral, and more prone to bleeding compared to sporadic AMLs, and the increased bleeding tendency in TSC patients necessitates more frequent monitoring 2, 3, 4, 5

Intratumoral aneurysms ≥5 mm dramatically increase bleeding risk and warrant closer monitoring or prophylactic treatment 2
A growth rate >0.5 cm/year (or >5 mm/year for fat-poor lesions) indicates higher risk and may warrant intervention 1, 2
Emergency transcatheter arterial embolization is the first-line treatment for bleeding AML, with successful outcomes using N-butyl cyanoacrylate glue 6
Nephron-sparing surgery is an acceptable alternative depending on local expertise and clinical circumstances 6

AMLs <4 cm should be monitored with ultrasound every 3 years 1, 2
AMLs 4-6 cm should be monitored with MRI or CT every 6-12 months 1
AMLs >6 cm should be monitored with MRI or CT every 6 months 2
Any size with intratumoral aneurysm ≥5 mm should consider prophylactic embolization 2
TSC patients should have more frequent monitoring regardless of size 2